TCL Archive The Pink Machine Sputters, Goes in Reverse: Komen Funding Decision Sparks Outrage February 03, 2012Vol.38 No.5
TCL Archive FASEB Delivers Its Recommendations For Federal Research Funding in 2013 February 03, 2012Vol.38 No.5
TCL Archive From One Competitive Market to Another: UC San Diego Stakes A Claim in Las Vegas January 27, 2012Vol.38 No.4
TCL Archive Regorafenib Trial Meets Primary Endpoint; Overall Survival Improved by 29 Percent January 27, 2012Vol.35 No.1
TCL Archive FDA Didn’t Punish Duke for Failing To Seek Proper Regulatory Clearance for Three Trials January 27, 2012Vol.38 No.4
TCL Archive Tesetaxel Showed 20 Percent Response In Second-Line Therapy In Phase IIb Trial January 27, 2012Vol.35 No.1
TCL Archive News Analysis by Keith Baggerly: Duke Trials Went On Despite FDA Statements January 27, 2012Vol.38 No.4
